Protein Powder Market Size & Share 2026-2035

Protein Powder Market Size

The global protein powder market was valued at USD 19 billion in 2025 and is projected to reach USD 33.4 billion by 2035, expanding at a 5.8% CAGR during 2026–2035.

The market is moving beyond its historic post-workout base as protein becomes a delivery format for muscle maintenance, satiety, clinical nutrition, and beauty-oriented collagen products. That expansion changes the purchasing criteria: flavor and convenience matter in mass wellness, while digestibility, protein density, clinical positioning, and documentation matter in medical and specialist channels.

Ingredient economics remain important. U.S. whey output increased from 93.6 million pounds in January 2024 to 97.8 million pounds in December 2024, providing a larger domestic byproduct pool for dairy-derived formulations ^{[1]USDA Agricultural Marketing Service, Dairy Products 2024 Summary, ams.usda.gov}. Global trade in protein concentrates and textured protein substances under HS 210610 reached USD 2.97 billion in 2024; the United States, China, and the Netherlands were leading exporters ^{[2]World Integrated Trade Solution, World Bank, Protein concentrates and textured protein substances exports by country, 2024 (HS 210610), wits.worldbank.org}. These flows do not equate to finished protein powder sales, but they indicate the cross-border ingredient infrastructure supporting both supplement and food-manufacturing formulations.

North America is the largest regional market at USD 7.29 billion in 2025, while Asia Pacific is the fastest-growing region, forecast at an 8.1% CAGR. Plant-based protein is also gaining revenue faster than the total market, rising from USD 3.57 billion in 2025 to USD 9.35 billion by 2035 at a 10.0% CAGR. Whey remains the largest protein type at USD 7.45 billion in 2025, but the category mix is set to shift toward plant-based protein, collagen, and clinically oriented formats rather than away from dairy altogether.

This broadening raises the value of formulation and channel fit. Dairy supply availability can support established whey brands, yet the faster-growing segments require different capabilities: allergen management and blending for plant-based products, evidence-backed claims for medical channels, and repeatable taste performance for daily-use products. Producers able to use a common ingredient platform across retail, clinical, and food-fortification formats can spread sourcing and quality-assurance costs; brands dependent on a narrow specialty-retail use case face a more limited path to growth.

Key Drivers

Fitness participation is widening the recurring-consumption base. The Health & Fitness Association reported 72.9 million memberships across surveyed markets in 2023, 13.5% above the 2019 level, while total membership increased 6% between 2023 and 2024 ^{[3]Health & Fitness Association, Fitness Industry's Global Momentum Continued in 2024, New Report Shows, 2025, healthandfitness.org}. Protein use is no longer confined to muscle gain: a Houlihan Lokey active-nutrition survey found muscle development, general health maintenance, workout recovery, and meal replacement among material consumption motivations ^{[5]Houlihan Lokey, Active Nutrition White Paper, November 2024, hl.com}. This matters because a user who treats powder as breakfast supplementation or recovery support is more likely to buy across the week than one purchasing only around competitive training.

Healthy aging and clinical nutrition create a higher-value demand path. Sarcopenia affects a meaningful share of adults aged over 60 globally, and reviews of dietary protein and amino-acid intake identify higher protein intake as relevant to mitigating age-related muscle loss ^{[6]Springer Nature, Effects of protein-based multinutrient therapy on sarcopenia in older adults: a systematic review and meta-analysis, 2025, link.springer.com}. Abbott's Ensure brand exceeded USD 3 billion in global sales in 2024, while adult nutrition grew 8.9% organically, demonstrating the commercial value of physician-facing and medically credible nutrition channels ^{[4]Abbott Laboratories, Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook, January 22, 2025, abbott.mediaroom.com}. The implication is not that all protein powder can command clinical pricing; it is that substantiation, palatability, and compliance can shift a product from discretionary sports consumption toward protocol-driven use.

Plant-protein processing is expanding formulation choice. PURIS reports a pea-protein carbon footprint of 0.2 kg CO2e per kilogram in its 2024 impact report. Beyond environmental positioning, pea capacity is becoming more industrialized: Roquette's Portage la Prairie facility was built to access concentrated yellow-pea supply, and Agriculture and Agri-Food Canada recorded 348 North American launches containing pea protein isolate between 2019 and 2023. Better availability and a larger installed processing base improve the feasibility of blends designed to manage taste, solubility, allergens, and amino-acid profiles.

Key Restraints

Affordability constrains premiumization in the markets with the strongest volume potential. Protein powders combine concentrated ingredients, flavor systems, packaging, testing, and, frequently, imported inputs. In India, regulatory attention to supplement quality and labeling adds compliance requirements in a market where lower-priced, poorly documented products have weakened trust. Brands cannot assume that a premium isolate or specialty plant blend will translate directly across income levels; locally appropriate pack sizes, formats, and sourcing can matter as much as headline protein content.

Regulatory fragmentation slows ingredient and claim innovation. EFSA frames food supplements within an EU safety and authorization system, while whey basic protein isolate received a specific novel-food authorization under Commission Implementing Regulation (EU) 2018/1632. India's framework separately regulates health supplements and protein-related claims, and FSSAI's 2024 draft amendments addressed whey protein concentrate and isolate standards, ^{[8]myFSSAI, FSSAI Draft Notification: FSS Food Products Standards and Food Additives Amendment Regulations, 2024, myfssai.in}. The commercial consequence is a longer route from formulation to cross-border launch, especially for products combining novel inputs with performance, aging, or beauty claims. Compliance capability therefore functions as a competitive asset, not merely an overhead cost.

Plant-based products illustrate the tension. Capacity investment and consumer acceptance support their 10.0% forecast CAGR, yet the overall market still grows at 5.8% because whey remains much larger and expands at 3.0%. Winning portfolios are likely to use plant proteins where their allergen, sustainability, or dietary advantages are valued, while retaining whey, casein, and blends where amino-acid density, familiarity, and cost-to-protein remain decisive.

Protein Powder Market Segment Analysis

By Type

Flavored products account for the dominant portion of retail and online protein powder demand because taste determines whether a powder can move from occasional post-exercise use into daily consumption. The active-nutrition survey documents use occasions spanning recovery, pre-workout, and meal replacement, while U.S. supplement sales data showed powders among the fastest-growing delivery formats in 2025, ^{[7]Nutraceuticals World, U.S. Supplement Sales Hit $72.88 Billion as Sports Nutrition and Digital Discovery Drive Growth, 2026, nutraceuticalsworld.com}. Flavor innovation therefore operates as a recruitment tool for recreational users and weight-management buyers, not simply as a product-line extension for athletes.

No eligible primary source validates a global flavored/unflavored split. Based on documented consumer adoption patterns, retail assortment, and the role of palatability in mainstream usage, flavored formats are estimated to represent roughly two-thirds to three-quarters of 2025 value, or approximately USD 13–14 billion of the USD 19.00 billion total. *Analyst decomposition estimate: calibrated to consumer adoption patterns and retail-channel evidence; no single eligible primary source provides a validated global flavored/unflavored split.*

Unflavored powders form the complementary minority, estimated at approximately USD 5–6 billion in 2025 as the residual of that estimate. Their demand is structurally different: clinical and food-fortification users need products that can be mixed into existing meals without changing flavor, and clean-label buyers often prefer a shorter ingredient list. The segment's growth is linked to versatility and institutional use rather than to displacement of flavored mainstream products.

By Source

Plant-based protein is projected to increase from USD 3.57 billion in 2025 to USD 9.35 billion by 2035 at a 10.0% CAGR. Soy remains the largest sub-type by established supply, processing maturity, complete amino-acid profile, and broad use in scaled plant-based formulations. Pea is the fastest-growing sub-type: Canadian and U.S. processing investment and the documented growth of pea-isolate product launches make it a more scalable alternative for brands managing soy avoidance or seeking a neutral positioning. Rice protein commonly plays a complementary blending role because its sensory and allergen attributes can improve a pea-based formula. Hemp, spirulina, quinoa, pumpkin seed, and faba bean remain niche or emerging inputs, with faba bean drawing interest for processing and agronomic attributes. Sub-type dollar allocations are not validated by eligible primary sources; the defensible ordering is soy as the largest current sub-type, pea as the fastest-growing, and rice as a complementary blend component.

Animal-based protein remains anchored by whey at USD 7.45 billion in 2025, rising to USD 10.02 billion in 2035 at a 3.0% CAGR. Whey concentrate serves broad-access formulations, isolate supports higher protein density and lower lactose positioning, and hydrolysate is used where rapid digestion or specialist formulation is important. North America is the largest whey market, supported by vertically integrated dairy supply chains and the USDA-documented increase in domestic whey output. Collagen is projected to grow from USD 1.59 billion to USD 4.34 billion at a 10.4% CAGR, reflecting its distinct beauty and joint-health consumption occasions. Casein rises from USD 2.34 billion to USD 3.34 billion, egg white from USD 1.24 billion to USD 1.67 billion, and blended/hybrid products from USD 2.81 billion to USD 4.68 billion. Blends are commercially useful where brands need to balance cost, taste, allergen positioning, and amino-acid coverage. Insect-derived protein remains nascent because consumer acceptance and regulatory authorization remain limiting factors.

By Application

Human nutrition is the principal finished-product demand base. Sports nutrition is the largest application, projected from USD 6.26 billion in 2025 to USD 8.68 billion in 2035 at 3.3% CAGR. Weight management rises from USD 3.48 billion to USD 5.34 billion, while general wellness rises from USD 3.10 billion to USD 4.68 billion. These products compete on convenience, flavor, and satiety-oriented positioning rather than on a single athletic-performance proposition.

The faster application pools have a different purchase logic. Beauty/skin health is forecast to grow from USD 1.40 billion in 2025 to USD 4.01 billion in 2035 at 10.9% CAGR, primarily through collagen-led formats. Healthy aging/sarcopenia is projected to rise from USD 1.78 billion to USD 4.68 billion at 10.0%, supported by aging-related muscle maintenance needs and clinical evidence on protein intake. Corporate wellness/cognitive products grow from USD 0.94 billion to USD 2.67 billion at 10.9%, while meal replacement reaches USD 3.34 billion from USD 2.04 billion. These higher-growth uses reward evidence, format flexibility, and channel partnerships more than conventional sports-brand visibility.

Animal nutrition covers aquaculture, poultry, swine, cattle, and horse applications, but it is adjacent to the finished protein powder market rather than a primary revenue driver within it. HS 210610 trade includes soy concentrates, textured proteins, and related ingredients that enter food and feed formulations; the United States exported about 106 million kg and China about 179 million kg in 2024. These bulk flows can improve utilization for ingredient suppliers, but they should not be treated as retail-packaged consumer powder revenue.

By End User

Athletes and bodybuilders remain the category's formulation reference point. Their demand favors protein-per-serving clarity, ingredient transparency, and, for professional users, third-party sports certification. Houlihan Lokey found muscle development and recovery to be leading motivations among protein-powder consumers. Eligible sources do not provide a validated standalone market value for this cohort; structural estimates place it at about one-quarter of total value based on specialty-channel concentration and purchase frequency.

Fitness enthusiasts, including gym-goers and recreational exercisers, are the largest and most heterogeneous cohort. Fitness participation has expanded across the United States, the UK, Germany, Spain, and Japan, widening the population that encounters protein through gyms, digital coaching, and online retail. This cohort spans post-workout buyers and consumers using powders for general health or meal replacement, supporting an estimated one-third of market value by proxy evidence; no eligible primary source validates a discrete dollar allocation.

Health-conscious consumers increasingly favor low-sugar, clean-label, and plant-based propositions. In U.S. natural retail, plant-based protein powder and liquid account for 35% of the broader protein-powder-and-liquid category, compared with 6% across the total channel, showing how strongly these preferences concentrate in natural retail. Clinical and medical users generate the highest revenue per unit because formulation evidence, professional recommendation, and reimbursement pathways can support higher-value products; Abbott's adult-nutrition performance demonstrates the scale of this channel. Teen and youth demand warrants a more guarded approach: research on adolescent supplementation finds limited performance benefits over whole-food protein in some outcomes and identifies safety and behavioral concerns associated with excessive use. No eligible evidence supports standalone dollar allocations for clinical/medical users or teenage/youth users.

By Distribution Channel

Online retail is structurally important because it combines assortment depth, subscription capability, and direct consumer data. iHerb recorded USD 2.4 billion in 2024 net sales, 37 million orders, and fulfillment across 180 countries. Digital discovery also lifted the broader U.S. supplement market, where sales reached USD 72.88 billion in 2025. For protein brands, online economics favor formulations that can be explained through product pages, reviews, and replenishment programs; the cost is a more transparent price environment and sustained spending on consumer acquisition.

Supermarkets and hypermarkets provide the discovery point for mainstream wellness buyers and favor brands able to protect shelf availability and communicate benefits simply. Specialty stores retain relevance where consumers seek technical comparison, immediate availability, or staff guidance, though they face structural pressure from online choice. Pharmacies and drugstores bridge consumer and clinical nutrition, particularly for elderly and recovery-related use cases. Other routes, including gyms, fitness centers, and direct-selling networks, remain useful for sampling and relationship-led recommendation; their advantage is trust, not the breadth of online assortment.

The stronger commercial response is portfolio architecture rather than a binary choice between animal and plant inputs. A company can use whey for performance credibility, collagen for beauty-oriented occasions, and pea-rice blends for dietary and allergen-led demand. Channel design must follow that architecture: e-commerce supports education and replenishment, pharmacies support clinical credibility, and specialty retail remains valuable for technical performance users. The constraint is executional: each route requires different claim substantiation, packaging, assortment, and price discipline.

Protein Powder Market Regional Analysis

North America

North America is valued at USD 7.29 billion in 2025 and is forecast to reach USD 11.02 billion by 2035 at a 4.2% CAGR. The United States is estimated at about 83% of regional revenue, or USD 6.05 billion in 2025, derived proportionally from the locked regional total. This is consistent with a U.S. active-nutrition market estimated at nearly USD 10 billion in 2024 and with sports nutrition representing 15.6% of the USD 72.88 billion U.S. supplement market in 2025. The estimate is directional rather than a primary-source-validated country market value.

Canada is estimated at about 14% of North American revenue, or USD 1.02 billion, also derived proportionally. It adds upstream importance through Prairie pea supply and protein-processing investment. Canada imported USD 198.4 million of HS 210610 protein concentrates in 2024 and USD 71.1 million of whey proteins under HS 040410, illustrating both demand for imported ingredients and its integration with U.S. supply.

Europe

Europe is projected to grow from USD 4.85 billion in 2025 to USD 8.02 billion in 2035 at a 5.2% CAGR. Germany and the UK are estimated at USD 0.73 billion and USD 0.68 billion, respectively, as proportional allocations from the regional total. Germany's USD 188 million of 2024 HS 210610 exports signals a meaningful processing base, while the UK's 15.9% fitness-participation penetration in 2023 supports a broad recurring consumer pool. France, Italy, and Spain are estimated at USD 0.58 billion, USD 0.49 billion, and USD 0.44 billion, respectively; Spain's 11.9% penetration provides one indicator of the region's widening fitness infrastructure. These country figures are proportional estimates calibrated to relative fitness participation and ingredient-trade indicators, not independently validated country revenue.

EU authorization requirements shape the regional product mix. Novel-food processes make early regulatory planning material for differentiated protein inputs. Atlantic Multipower, established in Hamburg in 1977, generated EUR 133.7 million in 2018 in the sports and functional nutrition business divested by Atlantic Grupa to Genuport Trade GmbH in 2019, illustrating the commercial viability of regionally specialized sports-nutrition routes to market.

Asia Pacific

Asia Pacific is the fastest-growing region, rising from USD 4.72 billion in 2025 to USD 10.35 billion in 2035 at an 8.1% CAGR. China is estimated at 42% of regional value, or USD 1.98 billion, and India at 18%, or USD 0.85 billion; both are proportional allocations from the locked regional total. China's role as a major exporter of HS 210610 ingredients, including roughly 179 million kg in 2024, demonstrates the scale of its processing ecosystem. South Korea and China lead regional sports-nutrition e-commerce, with online channels accounting for the majority of supplement revenue in both markets.

India combines a young urban consumer base with a tightening quality environment. FSSAI's regulatory activity on protein supplements can raise confidence in compliant brands while increasing the cost of participation for weakly documented products. Japan, estimated at USD 0.61 billion; Australia and New Zealand, estimated jointly at USD 0.47 billion; and South Korea, estimated at USD 0.38 billion, are likewise proportional estimates from the regional total. Japan's aging population favors clinically positioned protein and collagen use, while South Korea's digital channel strength favors premium functional-nutrition discovery. Eligible evidence does not provide comparable primary-source country revenue for these markets.

Latin America

Latin America grows from USD 1.33 billion in 2025 to USD 2.34 billion in 2035 at a 5.8% CAGR. Brazil is estimated at 45% of the regional total, or USD 0.60 billion, with Mexico at USD 0.40 billion and Argentina at USD 0.16 billion; these are proportional country estimates. Brazilian dairy-sector transactions and investment around whey fractionation point to a growing upstream capability that can reduce reliance on imported higher-value protein ingredients over time. In Mexico and Argentina, modern retail growth and local formulation can improve access, but currency and affordability pressures remain relevant to premium imported products.

Middle East & Africa

Middle East & Africa is forecast to expand from USD 0.81 billion in 2025 to USD 1.67 billion in 2035 at a 7.7% CAGR. Saudi Arabia and the UAE are estimated at USD 0.20 billion and USD 0.16 billion, South Africa at USD 0.15 billion, and the remainder at USD 0.30 billion, all derived proportionally from the locked regional total. Saudi Vision 2030 targets an increase in the share of citizens exercising weekly from 13% to 40% by 2030, linking health-participation policy to a larger addressable base for active nutrition. Halal compliance, affordability, and localized distribution are practical requirements in GCC markets rather than optional brand attributes.

Country estimates should be read as proportional allocations from the approved regional totals, not as independently validated primary-source market sizes. Their analytical value lies in identifying where operating conditions differ. Canada and Brazil matter partly as protein-input ecosystems; China and South Korea matter for digital discovery; India matters for compliant mass-market scaling; and Saudi Arabia's policy-led fitness participation creates a distinct active-nutrition demand driver. These differences favor regional product and go-to-market decisions over a uniform global SKU strategy.

Protein Powder Market Share & Competitive Landscape

Competition is fragmented at the finished-goods level but more concentrated in dairy and specialty ingredient supply. Differentiation rests on evidence, sensory performance, source choice, price architecture, and access to the right channel rather than on protein content alone.

Glanbia plc reported USD 3.84 billion of 2024 group revenue. Its Performance Nutrition business combines Optimum Nutrition, Isopure, and BSN with an ingredient platform; Optimum Nutrition represented about 66% of GPN revenue and recorded 7.5% constant-currency growth in 2024 ^{[9]Glanbia plc, 2024 Full Year Results, February 26, 2025, glanbia.com}. The combination gives Glanbia leverage in both branded performance nutrition and formulation supply.

Abbott Laboratories uses Ensure, Glucerna, and Juven to address adult and clinical nutrition. Its nutrition segment recorded USD 8.41 billion in 2024 sales, with adult nutrition at USD 4.39 billion and 8.9% organic growth. Abbott's advantage is institutional trust and healthcare-channel reach, which are difficult for sports-led brands to replicate.

GNC Holdings, Inc. reported USD 2.07 billion in revenue in fiscal 2019, before its 2020 restructuring, and operated 2,902 company-owned U.S. Canadian, and Puerto Rican stores plus 1,904 international franchise locations in approximately 50 countries. As a private company after acquisition by Harbin Pharmaceutical Group, it does not disclose comparable current annual revenue in the supplied primary sources. Its competitive relevance remains its specialty-retail footprint and proprietary protein portfolio, although ongoing e-commerce migration places pressure on store-led economics.

Herbalife Nutrition Ltd. generated USD 5.0 billion of 2024 net sales across 95 markets. Weight-management products accounted for 55.4% of sales, and energy, sports, and fitness products generated USD 572 million. Its distributor model creates recurring relationship-led demand, particularly where conventional retail coverage is less developed.

Amway Corporation reported USD 7.4 billion in 2024 sales, with nutrition contributing 64% of sales, or approximately USD 4.7 billion. Nutrilite's Gut Health Solutions combines plant protein, fiber, and probiotics, illustrating how direct sellers can position protein inside a broader wellness regimen rather than as a standalone sports product.

Nestlé S.A. recorded CHF 15.14 billion in 2024 sales in Nutrition & Health Science. Its Vital Proteins investment gives Nestlé Health Science a collagen platform spanning active nutrition and beauty-oriented consumption, while its medical-nutrition operations address clinical channels.

GSK Consumer Healthcare (Haleon) has broad consumer-health, pharmacy, and vitamins-minerals-supplements infrastructure, although its direct protein-powder presence is limited. GSK reduced its Haleon holding to 4.2% in January 2024 following the demerger, reinforcing Haleon's standalone consumer-health position. Its relevance is primarily channel access and wellness credibility rather than source-protein specialization.

Melaleuca Inc. sells whey-based Vitality Elevate Protein Shake with 30 g of protein per serving and a plant-based alternative with 21 g. Its membership model and broader supplement bundles, including the Peak Performance Pack, support relationship-led replenishment rather than open-market shelf competition.

Atlantic Multipower UK Limited / Atlantic Multipower requires a distinction between the dissolved UK entity and the active brand. Atlantic Multipower UK Limited was dissolved in December 2020. The Multipower brand, founded in Hamburg in 1977, is now operated within the Genuport Group following Atlantic Grupa's 2019 divestiture of its sports and functional nutrition business to Genuport Trade GmbH; that business generated EUR 133.7 million in 2018. Current revenue and country coverage are not publicly disclosed in the supplied eligible evidence.

Tata Consumer Products entered India's health-supplement market in 2022 through Tata GoFit, a women-focused, plant-based powder using pea and brown-rice protein. The product is soy-free, lactose-free, contains no added sugar, includes probiotics, and provides 18–25 g of protein per serving. Tata's established Indian consumer distribution gives it an avenue to make plant-based protein more accessible to mainstream health-focused buyers.

Recent Industry Developments

• April 2025: Actus Nutrition acquired a 99,000-square-foot whey protein processing facility in Sparta, Wisconsin, from Foremost Farms USA. The transaction expanded Actus's Wisconsin network to seven facilities and included a long-term whey-protein partnership with Foremost Farms.
• January 2025: Ferrero agreed to acquire Power Crunch, adding protein wafer bars and high-protein crisps to its better-for-you snack portfolio.
• 2024: Glanbia divested Body & Fit Benelux and SlimFast, while acquiring Flavor Producers to strengthen flavor-formulation capability and refocus on core performance nutrition.